This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Prognosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The clinical course of BCC is unpredictable; it may remain small for years with little tendency to grow, it may grow rapidly, or it may proceed by successive spurts of extension of tumour and partial regression (1)

The prognosis for a patient with basal cell carcinoma is very good as about 90% will be cured:

  • metastases is less than 1%
  • recurrence rate similar with surgery and radiotherapy 0.1-15%

There are several factors that may have an effect on recurrence rate including histological sub-type, other histological features, site, and other patient and tumour features. These are described in the linked item.

Reference:

  • Franchimont C et al. Episodic progression and regression of basal cell carcinomas. British Journal of Dermatology 1982;106(3):305-10.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.